GTR Home > Conditions/Phenotypes > Neural tube defects, folate-sensitive

Summary

Neural tube defects have a birth incidence of approximately 1 in 1,000 in American Caucasians and are the second most common type of birth defect after congenital heart defects. The most common NTDs are open spina bifida (myelomeningocele) and anencephaly (206500) (Detrait et al., 2005). Women with elevated plasma homocysteine, low folate, or low vitamin B12 (cobalamin) are at increased risk of having a child with a neural tube defect (O'Leary et al., 2005). Motulsky (1996) cited evidence from the Centers for Disease Control ( Anonymous, 1992) that folic acid given before and during the first 4 weeks of pregnancy can prevent 50% or more of neural tube defects. Botto et al. (1999) and Detrait et al. (2005) provided reviews of neural tube defects. De Marco et al. (2006) provided a detailed review of neurulation and the possible etiologies of neural tube defects. [from OMIM]

Genes See tests for all associated and related genes

  • Also known as: CIMAH, MTHFC, MTHFD, MTHFD1
    Summary: methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1

  • Also known as: , MTHFR
    Summary: methylenetetrahydrofolate reductase

  • Also known as: HMAG, MS, cblG, MTR
    Summary: 5-methyltetrahydrofolate-homocysteine methyltransferase

  • Also known as: MSR, cblE, MTRR
    Summary: 5-methyltetrahydrofolate-homocysteine methyltransferase reductase

Clinical features

Help

Show allHide all

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center